
Should Therapeutic Monitoring of Vancomycin Based on Area under the Curve Become Standard Practice for Patients with Confirmed or Suspected Methicillin-Resistant Staphylococcus aureus Infection? The “Pro” Side: Correction
Author(s) -
Kimberly C Claeys,
Karrine D. Brade,
Emily Heil
Publication year - 2020
Publication title -
canadian journal of hospital pharmacy/the canadian journal of hospital pharmacy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.262
H-Index - 22
eISSN - 1920-2903
pISSN - 0008-4123
DOI - 10.4212/cjhp.v73i4.3030
Subject(s) - staphylococcus aureus , vancomycin , methicillin resistant staphylococcus aureus , medicine , microbiology and biotechnology , biology , bacteria , genetics
-